← back to search

Barbara Höllbacher

Technical University of Munich · DE
Area of research
Immunology · Oncology
Research interest
Research interests include Biology, Lymph, Focus (optics), Antigen, Immunology, and Computational biology.
h-index
citations
412
works
3
NIH funding
primary concept
email

Recent publications

scPower accelerates and optimizes the design of multi-sample single cell transcriptomic studies
Nature Communications 2021cited by 96position: middledoi
Human CD4 <sup>+</sup> CD103 <sup>+</sup> cutaneous resident memory T cells are found in the circulation of healthy individuals
Science Immunology 2019cited by 250position: middledoi
Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance
The Journal of Immunology 2019cited by 66position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Daniel Campbell · Research Institute of Fundamental and Clinical Immunology2 papers (2019–2019) · 2 papers (2019–2019)Thomas Duhen · Cancer Institute (WIA)1 papers (2019–2019)Laurence A. Turka · Massachusetts General Hospital1 papers (2019–2019)S. Alice Long · Virginia Mason Medical Center1 papers (2019–2019)Cristiana Cruceanu · Karolinska Institutet1 papers (2021–2021)Kristina M. Harris · Immune Tolerance Network1 papers (2019–2019)Samia J. Khoury · American University of Beirut Medical Center1 papers (2019–2019)Heiko Lickert · Technical University of Munich1 papers (2021–2021) · 1 papers (2019–2019)Anika Böttcher · Technical University of Munich1 papers (2021–2021)Fabian J. Theis · University of Lübeck1 papers (2021–2021) · 1 papers (2019–2019)Leticia Kuri-Cervantes · Integrated BioTherapeutics (United States)1 papers (2019–2019) · 1 papers (2019–2019) · 1 papers (2019–2019) · 1 papers (2019–2019)Cathy Tan · University of California System1 papers (2019–2019)Eileen C. Goodwin · California University of Pennsylvania1 papers (2019–2019)Michael D. Rosenblum · University of California, San Francisco1 papers (2019–2019)